10 results
8-K
EX-99.3
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
of a Phase 3 clinical trial, or other “pivotal study” of a new drug to support marketing authorization, to submit a diversity action plan for such clinical … trial. The action plan must include the sponsor’s diversity goals for enrollment, as well as a rationale for the goals and a description of how
10-K
2020 FY
ELTX
Elicio Therapeutics Inc.
30 Mar 21
Annual report
5:00pm
and/or additional
Table of Contents
reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS
424B4
ELTX
Elicio Therapeutics Inc.
5 Feb 21
Prospectus supplement with pricing info
5:12pm
if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. Even when HIPAA does
DRS/A
cbj28v9xuz3d8 o49
15 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
cr67g59t b669ti
13 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next